Four genes indentified that influence levels of 'bad' cholesterol
Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the ...
Medical research
May 15, 2013 |
4.5 / 5 (2) |
0
|
Taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer, study finds
Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson ...
Cancer
May 02, 2013 |
not rated yet |
1
Regional anesthesia technique significantly improves outcomes of hip and knee replacement
A highly underutilized anesthesia technique called neuraxial anesthesia, also known as spinal or epidural anesthesia, improves outcomes in patients undergoing hip or knee replacement, according to a new study ...
Surgery
May 01, 2013 |
not rated yet |
0
Tart cherries linked to reduced risk of stroke
(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research ...
Health
Apr 24, 2013 |
3.8 / 5 (4) |
0
|
Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes
(Medical Xpress)—A laboratory study has shown for the first time that coenzyme Q10 offsets the cellular changes that are linked to a side-effect of some statin drugs - an increased risk of adult-onset diabetes.
Diseases, Conditions, Syndromes
Apr 10, 2013 |
4 / 5 (1) |
0
|
Cholesterol rafts deliver drugs inside cancer cells
DNA, siRNA and miRNA can reprogram cancer cells – that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published today in the journal Therapeutic Delivery shows ...
Cancer
Apr 02, 2013 |
4.5 / 5 (2) |
0
|
AstraZeneca settles legal dispute with Watson (Update)
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca has settled a patent dispute with Watson Laboratories, Inc., removing a threat against its top-selling cholesterol-control drug, Crestor.
Medications
Mar 25, 2013 |
not rated yet |
0
Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...
Cardiology
Mar 11, 2013 |
5 / 5 (2) |
0
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
The side effects of statin ads
Television advertising may drive over-diagnosis of high cholesterol and over-treatment with statins, according to a new study by Dr. Jeff Niederdeppe from Cornell University in the US and colleagues. It appears that a trip ...
Cardiology
Mar 07, 2013 |
not rated yet |
0
Internet searches can identify drug safety issues well ahead of public alerts
Internet searches on health symptoms can be used to identify drug side effects and could be used to develop a new kind of early warning system to boost drug safety, indicates a study published online in the Journal of th ...
Medications
Mar 06, 2013 |
not rated yet |
0
Drug OK'd for deadly genetic condition tied to cholesterol
(HealthDay)—Kynamro (mipomersen sodium) has been approved by the U.S. Food and Drug Administration to treat a rare inherited condition in which the body can't remove low-density lipoprotein (LDL) cholesterol from the blood.
Medications
Jan 30, 2013 |
not rated yet |
0
Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses than ...
HIV & AIDS
Jan 29, 2013 |
5 / 5 (1) |
0
|
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other
Jan 29, 2013 |
not rated yet |
0
Overlooked ugly cholesterol causes heart disease
The risk of ischaemic heart disease – a disease affecting some 150,000 Danes – is three times higher in persons with high levels of the so-called 'ugly' cholesterol. This is the finding of a new study of 73,000 Danes, ...
Cardiology
Jan 21, 2013 |
2.5 / 5 (2) |
0
